P. Vasey

1.3k total citations · 1 hit paper
7 papers, 649 citations indexed

About

P. Vasey is a scholar working on Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P. Vasey has authored 7 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Reproductive Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P. Vasey's work include Cancer Treatment and Pharmacology (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Neutropenia and Cancer Infections (2 papers). P. Vasey is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Neutropenia and Cancer Infections (2 papers). P. Vasey collaborates with scholars based in United Kingdom and France. P. Vasey's co-authors include Chris Twelves, Peter D. Wilson, Lilian S. Murray, T. E. Hilditch, J Cassidy, T. Murray, Rachel Morrison, Alison H. Thomson, E. Frigerio and Stan B. Kaye and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Oncology.

In The Last Decade

P. Vasey

7 papers receiving 632 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

1999 574 citations P. Vasey, Stan B. Kaye et al. PubMed profile →

Peers

P. Vasey

BIOMA

MB

BE

ONCOL

OC

Pooja Chandna United States

H Uchino Japan

Henrike Caysa Germany

Seock Ah Im South Korea

Dong-Wan Kim South Korea

Charles Engbers United States

Wenbin Dang United States

Jane-Guo Shiah United States

Yongen Sun United States

Rohit Sukumar United States

Pooja Chandna United States

P. Vasey

473 ×1.3

BIOMA

570 ×2.1

MB

252 ×1.3

BE

111 ×0.9

ONCOL

118 ×1.1

OC

Citations per year, relative to P. Vasey P. Vasey (= 1×) peers Pooja Chandna

Countries citing papers authored by P. Vasey

Since Specialization

Citations

This map shows the geographic impact of P. Vasey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Vasey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Vasey more than expected).

Fields of papers citing papers by P. Vasey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Vasey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Vasey. The network helps show where P. Vasey may publish in the future.

Co-authorship network of co-authors of P. Vasey

This figure shows the co-authorship network connecting the top 25 collaborators of P. Vasey. A scholar is included among the top collaborators of P. Vasey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Vasey. P. Vasey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Gourley, Charlie, J F Smyth, Melanie Mackean, et al.. (2006). Phase II study of letrozole in estrogen receptor (ER) positive relapsed epithelial ovarian cancer (EOC). Journal of Clinical Oncology. 24(18_suppl). 5025–5025. 12 indexed citations

2.

Poole, C. J., M. Gore, P. Vasey, et al.. (2005). Randomized phase II parallel evaluation of OSI-211 (liposomal lurtotecan) and topotecan in women with relapsed epithelial ovarian cancer (EOC). Journal of Clinical Oncology. 23(16_suppl). 5017–5017. 2 indexed citations

3.

Vasey, P., Henri Roché, D. Bisset, et al.. (2002). Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer. British Journal of Cancer. 87(10). 1072–1078. 3 indexed citations

4.

Vasey, P.. (2002). Survival and longer-term toxicity results of the SCOTROC study : docetaxel-carboplatin (DC) vs. paclitaxelcarboplatin (PC) in epithelial ovarian cancer (EOC) (abstract). Medical Entomology and Zoology. 21. 202. 33 indexed citations

5.

Twelves, Chris, C. Gardner, J Sludden, et al.. (1999). Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II. British Journal of Cancer. 80(11). 1786–1791. 23 indexed citations

6.

Vasey, P., Stan B. Kaye, Rachel Morrison, et al.. (1999). Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.. PubMed. 5(1). 83–94. 574 indexed citations breakdown →

7.

Vasey, P.. (1993). THE DEVELOPMENT OF ANTHRACYCLINE ANALOGS (REVIEW). International Journal of Oncology. 2(4). 677–81. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact